Senior insider sale
Chief Business Officer at JANUX THERAPEUTICS, INC. — senior position signals high conviction
$2.45M
141.45K shares
What this filing means
MEYER ANDREW HOLLMAN plans to sell 141.45K shares of JANUX THERAPEUTICS, INC. valued at approximately $2.45M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/23/2026ACC: 0001950047-26-000654
Officer· Chief Business Officer
Since Jun 2021
141.45K
Shares to sell
$2.45M
Approx. market value
118.12K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Exercise of options under a registered plan
Cash
1/23/2026
118.12KTotal acquired118.12K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/23/2026 | Exercise of options under a registered plan Cash | 118.12K | — |
| Total | 118.12K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
3.33K
Market value
$109.8K
12/1/2025
—Completed
Units to sell
3.33K
Market value
$99.8K
11/14/2025
—Completed
Units to sell
16.66K
Market value
$500.3K
10/28/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
118.12K
Market value
$1.74M
1/23/2026
Total
Units
141.45K
Value
$2.45M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/1/2025 | 3.33K | $109.8K | — | Completed |
11/14/2025 | 3.33K | $99.8K | — | Completed |
10/28/2025 | 16.66K | $500.3K | — | Completed |
| Planned — Approximate Date | ||||
1/23/2026 | 118.12K | $1.74M | NASDAQ | Planned |
| Total | 141.45K | $2.45M | ||